+86 137 2013 4139
+86 137 2013 4139
| CAS: | 2050057-56-0 | Cat No: | JKN01000 | Purity: | 98% |
Note: All products of the company are for scientific research only, and do not provide products and services for any individual
Product Description
| CAS | 2050057-56-0 | Cat No | JKN01000 | |
| Name | Upadacitinib hemihydrate | |||
| Synonyms | Upadacitinib hemihydrate | |||
| Smiles | CC[C@@H]1CN(C[C@@H]1C2=CN=C3N2C4=C(NC=C4)N=C3)C(=O)NCC(F)(F)F.CC[C@@H]1CN(C[C@@H]1C2=CN=C3N2C4=C(NC=C4)N=C3)C(=O)NCC(F)(F)F.O | |||
| Chemical Name | (3S,4R)-3-ethyl-4-(1,5,7,10-tetrazatricyclo[7.3.0.02,6]dodeca-2(6),3,7,9,11-pentaen-12-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide;hydrate | |||
| Formula | C34H40F6N12O3 | MWt | 778.8 | |
| Purity | 98% | Storage | Store at 4--8℃ | |
| Description | UPADACITINIB HEMIHYDRATE is a small molecule drug with a maximum clinical trial phase of IV that was first approved in 2019 and is indicated for rheumatoid arthritis. This drug has a black box warning from the FDA. | |||
Product Documents
Menu
Contact Us
Tel: +86 137 2013 4139
E-mail: orders@jknbiochem.com
Add.:Room 2120, Office Building 2, No.1 Baisha Fifth Road, Hongshan District, Wuhan City, Hubei Province, China
Get In Touch
Get In Touch
